Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Head & Neck 3Gastrointestinal 3Other solid neoplasm 2Other neoplasm 1

Conditions

Solitary Fibrous Tumor, Pleural 1Mesothelioma, Malignant 1Epitheliod Malignant Pleural Mesothelioma 1

Interventions

Cisplatin 42Pemetrexed 31Carboplatin 28Nivolumab 21pembrolizumab 19Gemcitabine 19atezolizumab 13Etoposide 13Injections 12Ipilimumab 11Cyclophosphamide 11Radiotherapy 10Oxaliplatin 10Filgrastim 10Docetaxel 10Bevacizumab 10tislelizumab 9Vincristine 9Specimen Handling 9durvalumab 8Paclitaxel 8Capecitabine 8tremelimumab 7toripalimab 7lenvatinib 7Everolimus 7spartalizumab 6olaparib 6niraparib 6Vinorelbine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Dihematoporphyrin Ether × Other solid neoplasm × Clear all
NCT02153229 2025-12-26

MPM-PDT

Abramson Cancer Center at Penn Medicine

Phase 2 Active not recruiting
52 enrolled
Other solid neoplasmThoracic

Epitheliod Malignant Pleural Mesothelioma

NCT00054002 2011-03-01

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

Roswell Park Cancer Institute

Phase 2 Completed
12 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡